InflaRx NV (IFRX)
1.585
-0.02
(-0.94%)
USD |
NASDAQ |
Oct 12, 16:00
1.585
0.00 (0.00%)
After-Hours: 20:00
InflaRx Free Cash Flow (Quarterly) : -2.979M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.979M |
| March 31, 2026 | -8.660M |
| September 30, 2025 | -11.43M |
| June 30, 2025 | -9.714M |
| March 31, 2025 | -14.76M |
| September 30, 2024 | -11.21M |
| June 30, 2024 | -12.94M |
| March 31, 2024 | -16.15M |
| December 31, 2023 | -11.37M |
| September 30, 2023 | -5.725M |
| June 30, 2023 | -12.34M |
| March 31, 2023 | -11.29M |
| December 31, 2022 | -5.848M |
| September 30, 2022 | -1.737M |
| June 30, 2022 | -12.56M |
| March 31, 2022 | -14.43M |
| December 31, 2021 | -12.41M |
| Date | Value |
|---|---|
| September 30, 2021 | -11.25M |
| June 30, 2021 | -9.467M |
| March 31, 2021 | -12.56M |
| December 31, 2020 | -12.20M |
| September 30, 2020 | -11.32M |
| June 30, 2020 | -8.485M |
| March 31, 2020 | -11.62M |
| December 31, 2019 | -17.79M |
| September 30, 2019 | -9.095M |
| June 30, 2019 | -11.67M |
| March 31, 2019 | -9.938M |
| December 31, 2018 | -9.631M |
| September 30, 2018 | -4.640M |
| June 30, 2018 | -6.524M |
| March 31, 2018 | -7.182M |
| December 31, 2017 | -4.482M |
| September 30, 2017 | -4.196M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| MediGene AG | -- |
| BioNTech SE | -52.17M |
| Immatics NV | -71.00M |
| Arrowhead Pharmaceuticals, Inc. | -181.32M |
| Oncolytics Biotech, Inc. | -8.066M |